Voyageur Pharmaceuticals (CVE:VM) Trading 24.1% Higher – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price traded up 24.1% during trading on Monday . The company traded as high as C$0.18 and last traded at C$0.18. 201,820 shares were traded during trading, an increase of 134% from the average session volume of 86,131 shares. The stock had previously closed at C$0.15.

Voyageur Pharmaceuticals Trading Up 20.7%

The company has a current ratio of 0.10, a quick ratio of 0.84 and a debt-to-equity ratio of 4.23. The company has a market cap of C$31.23 million, a price-to-earnings ratio of -8.75 and a beta of 0.63. The firm has a 50-day moving average price of C$0.16 and a 200 day moving average price of C$0.16.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.